Hepatitis C Trial on Controlled Release Interferon Underway
Dosing has started for a Phase 2b study of Locteron®, an every-other-week, controlled release, interferon alpha-2b medication to treat Hepatitis C.
Continue reading »Research & Treatment News
Share
Follow Us
Preventing Bleeding Varices: A Liver Transplant Must
Information about preventing a complication of advanced Hepatitis C infection is now available. Learn why scientists are considering beta blockers to be the best line of defense against bleeding varices, a condition prohibitive of a liver transplant and one that can also be life threatening.
Continue reading »HCV Combination Therapy Approved for Non-Responders
Already approved in Europe and the United States, Viraferonpeg combination therapy is now approved for re-treating Hepatitis C non-responders in India.
Continue reading »Insight Into Clearing the Hepatitis B and C Viruses
By investigating co-infection and interferon therapy, two Italian studies look into the future of Hepatitis B and Hepatitis C therapy.
Continue reading »Perspective on the Progression of Hepatitis C
Those with Hepatitis C likely know that their disease can get worse, but may want to know more about the average speed of liver disease progression.
Continue reading »Do Sunlight and Hepatitis C Meds Mix?
Sun exposure has health benefits specific to those with Hepatitis C, yet it may be cautioned for those on combination treatment. Knowing about photosensitivity can help you overcome this Catch-22.
Continue reading »Smoking with Hepatitis C Raises Liver Cancer Risk
New research demonstrates that a man with Hepatitis C who smokes has a radically greater chance of getting liver cancer than those who steer clear of cigarettes.
Continue reading »Male Sexual Function During Hepatitis C Treatment
A new study presented at the November 2008 Annual Meeting of the American Association for the Study of Liver Diseases... View Article
Continue reading »Inhibiting the Hepatitis C Virus
Opening up new treatment possibilities, researchers from Scripps Institute have found molecules that prevent Hepatitis C viral production.
Continue reading »FDA Expands Use of Schering's Hepatitis C Drugs
While previously only approved for patients who had never taken any Hepatitis C drugs, Pegintron and Rebetol are now approved by the FDA for re-treatment.
Continue reading »
